Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Getein Biotech Inc

603387
Current price
8.67 CNY -0.24 CNY (-2.69%)
Last closed 8.94 CNY
ISIN CNE100002RR9
Sector Healthcare
Industry Medical Devices
Exchange Shanghai Stock Exchange
Capitalization 4 508 935 352 CNY
Yield for 12 month -25.52 %
1Y
3Y
5Y
10Y
15Y
603387
21.11.2021 - 28.11.2021

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China. Address: No.9 Bofu Road, Nanjing, China, 211505

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

270.33 CNY

P/E ratio

17.74

Dividend Yield

Current Year

+1 372 351 921 CNY

Last Year

+1 826 104 988 CNY

Current Quarter

+296 774 836 CNY

Last Quarter

+322 331 886 CNY

Current Year

+925 247 714 CNY

Last Year

+1 188 230 180 CNY

Current Quarter

+198 391 039 CNY

Last Quarter

+230 385 431 CNY

Key Figures 603387

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 327 275 642 CNY
Operating Margin TTM 28.66 %
PE Ratio 17.74
Return On Assets TTM 3.7 %
PEG Ratio
Return On Equity TTM 9.52 %
Wall Street Target Price 270.33 CNY
Revenue TTM 1 250 932 286 CNY
Book Value 5.13 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -11.9 %
Dividend Yield
Gross Profit TTM 1 188 230 178 CNY
Earnings per share 0.5 CNY
Diluted Eps TTM 0.5 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -8.1 %
Profit Margin 20.27 %

Dividend Analytics 603387

Dividend growth over 5 years

83 %

Continuous growth

Payout Ratio 5 years average

29 %

Dividend History 603387

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 19.09.2024
Forward Annual Dividend Yield
Last Split Factor 1.4:1
Payout Ratio 38 %
Last Split Date 08.06.2022
Dividend Date

Stock Valuation 603387

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 17.74
Forward PE
Enterprise Value Revenue 3.2376
Price Sales TTM 3.5801
Enterprise Value EBITDA 13.4779
Price Book MRQ 1.7327

Financials 603387

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 603387

For 52 weeks

6.88 CNY 12.2 CNY
50 Day MA 7.97 CNY
Shares Short Prior Month
200 Day MA 8.52 CNY
Short Ratio
Shares Short
Short Percent